6. Prognosis

From Clinical Guidelines Wiki


Introduction

With prompt detection and effective treatment, basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) generally carry a good prognosis. These tumours are rarely fatal, causing only approximately 560 deaths each year in Australia.[1]

Outcomes generally reported in clinical trials BCC and cSCC management include recurrence, 5-year survival and treatment-related morbidity. These outcomes are influenced by tumour stage, site, morphological and histological subtype, treatment modality and excision margins.

Back to top

References

  1. Australian Institute of Health and Welfare. Skin cancer in Australia. Canberra, ACT: AIHW, Department of Health; 2016 Jul 13 [cited 2018 Oct 8]. Report No.: CAN 96. Available from: https://www.aihw.gov.au/reports/cancer/skin-cancer-in-australia/contents/table-of-contents.

Back to top